Showing 21 - 40 of 102 results
Sharing expertise with regional neighbours
Participants undertook IAEA training hosted by Macquarie University and ANSTO on use of radionuclides for soil and water investigations.
Australian Synchrotron to join consortium mapping the human brain
Consortium will map the 86 billion nerve cells, 100 trillion connections and neurotransmitters in the human brain.
Research brings new insights to the complex immune response in the brain
Role at ANSTO
New partnership
Australia and Sri Lanks signs new partnership to fight chronic kidney disease.
Funding backs ANSTO‑led program to develop new treatment for deadly brain cancers
ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program
PET innovation
Tool developed for producing F-18 radiopharmaceuticals for PET imaging.
Making science accessible to everyone: new initiative for the Deaf community
ANSTO was proud to support the first science-themed AuslanX event for the greater Sydney Deaf community during National Science Week.
A closer look at the science of detecting flu
A landmark year and bright future at the Australian Synchrotron
ANSTO taking part in international coastal pollution studies
Immune system's friendly fire can turn malaria deadly
Australian researchers reveal how the immune system’s ‘friendly fire’ can turn malaria deadly
Role at ANSTO
Meet some of the women from the history of ANSTO who were pioneers in their time
The celebration of the UN’s International Women’s Day 2023 has a theme that highlights the power of innovative IT to combat discrimination and the marginalisation of women globally.
Business case to inform direction of Australian nuclear medicine
Consultant appointed to consider a variety of financial, manufacture and import options.
Tracking oxytocin to understand the biological pathways linked to human cognition and behaviour
Innovative cancer research
An ANSTO radiochemist has been awarded a scholarship to carry out research at the world-renowned Sloan Kettering Cancer Center in New York.
Helium 3 Polariser
This state-of-the-art metastable-exchange optical-pumping helium-3 polarising system enables polarisation-analysis experiments on five of our existing instruments.